Deal of the Day — limited-time pharmacy picks!
Rituxirel 500mg/50ml Injection

Rituxirel 500mg/50ml Injection

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Rituximab

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 Injection

About The Product

Cancer Medicines, Lymphoma Cancer


Description

Rituxirel 500mg/ 50ml Injection is a monoclonal antibody. It is used to treat many types of cancers such as to treat non-hodgkin’s lymphoma and chronic lymphocytic leukemia. It is also indicated to treat moderate-to-severe rheumatoid arthritis in patients. Its active ingredient is rituximab which belongs to the group class of anti-CD20 monoclonal antibodies (immunosuppressive agents).

It works by binding to the CD20 antigen on B cells. The effect helps control B cell proliferation in cancers and modulate immune responses in certain autoimmune disorders. The dosage and administration must be followed as directed by the healthcare professional to ensure safe and effective treatment option.

​

Uses

  • Non- hodgkin's lymphoma, chronic lymphocytic leukemia and moderate to severe rheumatoid arthritis

Side Effects

  • Rituxirel 500mg/ 50ml Injection can cause certain side effects some are acute and some are mild.
  • If any of the symptoms persist or worsen, consult the healthcare professional instantly: • Anemia • Muscle spasm • Headache • Urinary tract infection • Fever, chills, and shivering • Inflammation of nasal cavities • Cough, sore throat • Loss of hair • Swelling in the face and body • Diarrhea and nausea • Itchy skin • Increased or decreased blood pressure • Chest pain • Hypersensitivity reactions • Hepatitis B viral infection • Memory loss, trouble thinking, difficulty walking

How To Use

  • Rituxirel 500mg/ 50ml Injection can be taken with or without food at the fixed time everyday to enhance the effectiveness of the treatment. It can be taken by a nurse in a hospital through the skin through intravenous infusion into a vein under medical supervision.
  • Consult the healthcare professional about the correct dosage and duration to ensure safe and effective treatment option.

​

How It Works

  • Rituxirel 500mg/ 50ml Injection is an anticancer medication that binds to the CD20 antigen on B lymphocytes. After binding it causes B cell destruction through complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC), and direct apoptosis.
  • This leads to depletion of CD20 positive B cells while sparing stem cells. As a result, it blocks B cells and reduces the size of cancer cells in the body.

Safety Advice

Alcohol
Rituxirel 500mg/ 50ml Injection may cause certain side effects while consuming alcohol. Consult the doctor if the symptoms persist.
Pregnancy
Pregnant women should consult the healthcare supervision whether if Rituxirel 500mg/ 50ml Injection should be taken or not to avoid complications during the treatment.
Breast Feeding
Rituxirel 500mg/ 50ml Injection is passed through the breast milk which is harmful for the baby. Doctor will tell you better about the dosage and duration.
Driving
Driving should avoid while taking Rituxirel 500mg/ 50ml Injection as it may cause dizziness and Weakness. Also avoid using machinery while using the medication.
Kidney
Rituxirel 500mg/ 50ml Injection may interfere with the kidney function. If the person is a kidney patient, they should take a proper prescription to the doctor.
Liver
Rituxirel 500mg/ 50ml Injection may harmful for liver patient as it can be disrupt the liver function and harm the liver In many ways. It is necessary to consult a healthcare professional before using the injection.

FAQs

Rituxirel 500mg/ 50ml Injection can be taken with other medication but the doctor prescription as doctor will decide the dosage and duration with other medication based on the patient medical history and response to the treatment.

References

  • Grillo-López, A. J., Hedrick, E., Rashford, M., & Benyunes, M. (2002, February). Rituximab: ongoing and future clinical development. In Seminars in oncology (Vol. 29, No. 1, pp. 105-112). WB Saunders. https://www.sciencedirect.com/science/article/abs/pii/S0093775402500853
  • Cohen, M. D., & Keystone, E. (2015). Rituximab for rheumatoid arthritis. Rheumatology and therapy, 2(2), 99-111. https://pubmed.ncbi.nlm.nih.gov/27747531/
  • Borker, A., & Choudhary, N. (2011). Rituximab. Indian pediatrics, 48(8), 627-632. https://pubmed.ncbi.nlm.nih.gov/21918268/
  • Maloney, D. G., Smith, B., & Rose, A. (2002, February). Rituximab: mechanism of action and resistance. In Seminars in oncology (Vol. 29, No. 1, pp. 2-9). WB Saunders. https://pubmed.ncbi.nlm.nih.gov/11842383/
  • Rezvani, A. R., & Maloney, D. G. (2011). Rituximab resistance. Best practice & research Clinical haematology, 24(2), 203-216. https://pubmed.ncbi.nlm.nih.gov/21658619/​

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026